Primary biliary cholangitis affects an estimated 30,000 to 50,000 people in the United States, with women making up about 75 to 80 percent of cases.

The European Commission (EC) has conditionally approved Ipsen’s Iqirvo (elafibranor) for the treatment of primary biliary cholangitis (PBC), becoming the first drug approved for the liver ...

Sclerosing cholangitis and primary biliary cirrhosis, which is now called primary biliary cholangitis (PBC), are chronic cholestatic liver diseases, but they differ in their causes, affected bile ...

Primary Sclerosing Cholangitis is a rare disease that has an impact on the bile duct. More than 25+ companies are involved in product development in different stages of development including ...

What Carrington didn’t know then was that she was about to go through the frustrating experience of getting diagnosed with primary biliary cholangitis (PBC), an autoimmune disease that affects ...

Primary billiary cholangitis, or PBC, is a chronic disease that gradually damages the bile ducts, and eventually your liver. You may also hear it called primary billiary cirrhosis. Your bile ducts ...

Once clinical suspicion has been established for primary biliary cholangitis (PBC), the " serologic hallmark" of the autoimmune disease are anti-mitochondrial antibodies (AMA), present in ...

Primary sclerosing cholangitis (PSC) is a chronic autoimmune disease with inflammation and stricture formation in the bile ducts inside the liver and/or in the extrahepatic bile duct which drains into ...

Perspective > Medscape Gastroenterology > Hepatology Highlights COMMENTARY Primary Biliary Cholangitis: The Latest Data on an Evolving Disorder Rowen K. Zetterman, MD Disclosures January 04, 2019 0 ...

Linerixibat, an ileal sodium-dependent bile acid transporter inhibitor, improved more than itch for patients with primary biliary cholangitis, despite a notable placebo effect, in the GLIMMER trial.

Topline results were announced from a phase 3 trial evaluating linerixibat for the treatment of cholestatic pruritus in patients with primary biliary cholangitis (PBC). Linerixibat is an ...